Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$740,713 | -$703,754 | -$857,766 | -$373,636 |
| Dep. & Amort. | $111,109 | $124,787 | $112,352 | $51,621 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $309,591 | -$117,430 | -$129,783 | -$150,591 |
| Other Non-Cash | $343,752 | $86,378 | $145,738 | $15,689 |
| Operating Cash Flow | $23,739 | -$610,019 | -$729,459 | -$456,917 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$33,916 | -$260,636 | -$169,980 | -$125,459 |
| Net Acquisitions | -$483 | -$3,541 | -$813,494 | -$175,667 |
| Inv. Purchases | -$426 | -$44,740 | -$91,835 | -$419,849 |
| Inv. Sales/Matur. | $0 | $22,270 | $0 | $54,142 |
| Other Inv. Act. | $14,927 | -$60,212 | $3,043 | $13,795 |
| Investing Cash Flow | -$19,898 | -$346,859 | -$1,072,266 | -$653,038 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$423,138 | -$130,335 | $701,684 | -$20,252 |
| Stock Issued | $0 | $0 | $0 | $1,191,332 |
| Stock Repurch. | $0 | $0 | $0 | -$72,548 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$64,201 | -$43,651 | -$66,547 | $292,869 |
| Financing Cash Flow | -$487,339 | -$173,986 | $635,137 | $1,391,401 |
| Forex Effect | $7,138 | $25,829 | $90,807 | -$34,404 |
| Net Chg. in Cash | -$476,360 | -$1,105,035 | -$1,075,781 | $247,042 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $774,396 | $1,879,431 | $2,955,212 | $2,708,170 |
| End Cash | $298,036 | $774,396 | $1,879,431 | $2,955,212 |
| Free Cash Flow | -$17,817 | -$872,927 | -$908,233 | -$602,081 |